Chemomab Therapeutics Ltd.
(NASDAQ : CMMB)

( )
CMMB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.21%161.910.0%$1387.78m
NVAXNovavax, Inc. -2.57%221.5080.0%$650.79m
AMGNAmgen, Inc. 0.10%255.971.3%$554.37m
SNSSSunesis Pharmaceuticals, Inc. -5.63%7.550.7%$527.77m
ILMNIllumina, Inc. 1.30%404.183.5%$527.33m
REGNRegeneron Pharmaceuticals, Inc. -0.58%499.692.7%$447.00m
GILDGilead Sciences, Inc. -1.38%65.951.0%$437.06m
VRTXVertex Pharmaceuticals, Inc. -0.10%219.181.9%$383.57m
ALXNAlexion Pharmaceuticals, Inc. 1.09%165.472.0%$360.29m
BNTXBioNTech SE -1.36%149.480.0%$336.51m
BIIBBiogen, Inc. -0.47%269.051.7%$246.78m
NBIXNeurocrine Biosciences, Inc. -1.79%94.854.9%$180.78m
EXASEXACT Sciences Corp. -1.93%127.5318.4%$168.47m
CRSPCRISPR Therapeutics AG -2.97%115.040.6%$158.56m
SGENSeagen Inc. -1.02%144.015.8%$140.14m

Company Profile

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.